COSCIENS Biopharma Inc. (CSCI) — Cash Flow Reinvestment Rate
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow Reinvestment Rate of 0.52x as of September 2023, reinvesting $75.15K (capex $8.92K plus investments $-66.24K) from operating cash flow of $144.00K. Check CSCI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Cash Flow Reinvestment Rate (2003–2022)
Historical reinvestment intensity for COSCIENS Biopharma Inc. across 13 annual periods. Explore COSCIENS Biopharma Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year capital reinvestment analysis for COSCIENS Biopharma Inc.. For live market cap and broader valuation context, see CSCI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $399.39K | $5.23 Million | $10.57K | ▼ -84.4% |
| 2021 | 0.49x | $1.35 Million | $2.75 Million | $555.99K | ▲ +76.2% |
| 2020 | 0.28x | $969.60K | $3.49 Million | $485.46K | ▲ +5372320.5% |
| 2019 | 0.00x | $3.49 | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $3.20 Million | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.71 Million | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $3.03 Million | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $3.98 Million | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $2.16 Million | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $123.30K | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $85.01K | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $66.73K | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $103.05K | $54.42K | $103.05K | — |